BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20021455)

  • 21. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
    Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
    Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.
    Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT
    Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Jab1 is a specificity factor for E2F1-induced apoptosis.
    Hallstrom TC; Nevins JR
    Genes Dev; 2006 Mar; 20(5):613-23. PubMed ID: 16481464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL; Weaks RL; Berton TR; Johnson DG
    Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.
    Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Komori H; Ohtani K
    Biochem Biophys Res Commun; 2014 Jul; 450(1):240-6. PubMed ID: 24893334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E2F1-directed activation of Bcl-2 is correlated with lactoferrin-induced apoptosis in Jurkat leukemia T lymphocytes.
    Lee SH; Hwang HM; Pyo CW; Hahm DH; Choi SY
    Biometals; 2010 Jun; 23(3):507-14. PubMed ID: 20411301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E2F1 inhibits MDM2 expression in a p53-dependent manner.
    Tian X; Chen Y; Hu W; Wu M
    Cell Signal; 2011 Jan; 23(1):193-200. PubMed ID: 20837136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation-mediated regulation of E2F1 in DNA damage-induced cell death.
    Xie Q; Bai Y; Wu J; Sun Y; Wang Y; Zhang Y; Mei P; Yuan Z
    J Recept Signal Transduct Res; 2011 Apr; 31(2):139-46. PubMed ID: 21320024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
    Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
    Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E2F is involved in radioresistance of carbon ion induced apoptosis via Bax/caspase 3 signal pathway in human hepatoma cell.
    Xie Y; Si J; Wang YP; Li HY; Di CX; Yan JF; Ye YC; Zhang YS; Zhang H
    J Cell Physiol; 2018 Feb; 233(2):1312-1320. PubMed ID: 28500630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of E2F1 during ER stress is required to induce apoptosis.
    Pagliarini V; Giglio P; Bernardoni P; De Zio D; Fimia GM; Piacentini M; Corazzari M
    J Cell Sci; 2015 Mar; 128(6):1166-79. PubMed ID: 25616897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
    Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
    Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription factor NF-Y induces apoptosis in cells expressing wild-type p53 through E2F1 upregulation and p53 activation.
    Gurtner A; Fuschi P; Martelli F; Manni I; Artuso S; Simonte G; Ambrosino V; Antonini A; Folgiero V; Falcioni R; Sacchi A; Piaggio G
    Cancer Res; 2010 Dec; 70(23):9711-20. PubMed ID: 20952509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E2F1 death pathways as targets for cancer therapy.
    PĆ¼tzer BM
    J Cell Mol Med; 2007; 11(2):239-51. PubMed ID: 17488475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2F1 pathways to apoptosis.
    Ginsberg D
    FEBS Lett; 2002 Oct; 529(1):122-5. PubMed ID: 12354623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.
    Hsieh JK; Fredersdorf S; Kouzarides T; Martin K; Lu X
    Genes Dev; 1997 Jul; 11(14):1840-52. PubMed ID: 9242491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T; Chaussepied M; Oren M; Ginsberg D
    Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.
    Pierce AM; Gimenez-Conti IB; Schneider-Broussard R; Martinez LA; Conti CJ; Johnson DG
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8858-63. PubMed ID: 9671769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.